HR Execs on the Move

Treace Medical Concepts

www.treace.com

 
Treace Medical Concepts, Inc. brings revolutionary Hallux Valgus Surgery. A revolutionary approach to anatomic bunion correction. Call us today 904.373.5940.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.treace.com
  • 3107, Sawgrass Village Cir
    Ponte Vedra Beach, FL USA 32082
  • Phone: 904.373.5940

Executives

Name Title Contact Details
Jason Gregg
Regional Vice President of Sales Profile
Rolanda Gordon
Sr. Director, Financial Planning and Analysis Profile

Similar Companies

Theradex Oncology Experts

Theradex is an international contract research organization providing complete professional services for the clinical research and development of pharmaceutical compounds, medical devices and diagnostic tests in the areas of oncology and

Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, leveraging technology from the lab of Nobel laureate Dr. Paul Greengard, for the treatment of neuropsychiatric and neurodegenerative diseases. The Company is developing its lead drug candidate, lumateperone, a first-in-class molecule, which is in Phase 3 clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia, including Alzheimer`s disease. The Company is also utilizing its phosphodiesterase (PDE) platform and other proprietary chemistry platforms to develop drugs for the treatment of CNS and other disorders. The lead compound in the PDE platform, ITI-214, a PDE1 inhibitor is being developed for the treatment of CNS and non-CNS indications.

Validation and Engineering Group

Validation & Engineering Group is a Guaynabo, PR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Metabolic Solutions Development

Metabolic Solutions Development Company, LLC (MSDC) discovers and develops novel molecular targets and new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company has raised nearly $55 million in support of the development of its novel therapeutic drugs, MSDC-0160 and MSDC-0602, which selectively modulate mitochondrial control of to important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, that are out of balance in patients with type 2 diabetes. Such imbalances may also play a role in other diseases of aging such as Alzheimer’s disease and Parkinson’s disease, as well certain genetic diseases such as polycystic kidney disease.

Apple Discount Drugs

Apple Discount Drugs is a Salisbury, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.